Skip to content
Clinical Trials – home
GermanyBack to Germany

Clinical trials in Eisenach

7 clinical trials in Eisenach, Germany. Every trial is listed in the EU Clinical Trials Register and updated daily.

GermanyOur site in GermanyKlinischeStudien.de(opens in a new tab)
Eisenach at a glance
7
clinical trials
  • Paediatric trials0
  • Research sites0
Type of trial
Recruitment status
Quick filters

7 trials in Eisenach

Open in trial search
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Azd5004
  • Sponsor:AstraZeneca AB
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Bi 690517
  • Sponsor:Boehringer Ingelheim Espana S.A.
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Acalabrutinib
  • Sponsor:University Of Cologne
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:INSULIN DEGLUDEC
  • Sponsor:Novo Nordisk A/S
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Insulin Glargine
  • Sponsor:Novo Nordisk A/S
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Capecitabine
  • Sponsor:Technische Universitaet Dresden
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Canagliflozin
  • Sponsor:Eli Lilly & Co.

Other cities in Germany

The busiest research cities in the country

All 515 cities in Germany

Clinical research in Eisenach

What the registry says about research in the country

01 Diabetes & Metabolic Disorders

Innovative research focusing on Type 2 Diabetes management, comparing advanced therapeutic options for patients with cardiovascular risk factors. Studies are evaluating new treatments that could offer improved glycemic control.

  • Diabetes with cardiovascular complications
  • Obesity management
  • Metabolic health optimization

These trials aim to enhance treatment outcomes for patients with multiple metabolic conditions.

02 Oncology Research

Groundbreaking studies in colon cancer treatment, particularly focusing on stage II patients. Research includes evaluation of circulating tumor DNA to guide adjuvant therapy decisions.

  • Personalized cancer treatment
  • Post-surgical therapy optimization
  • Disease-free survival assessment

The research aims to improve treatment precision and patient outcomes.

03 Hematologic Oncology

Advanced research in Chronic Lymphocytic Leukemia, examining novel combination therapies for high-risk patients. Studies focus on improving progression-free survival through targeted treatment approaches.

  • High-risk leukemia management
  • Novel drug combinations
  • Targeted therapy evaluation

These trials represent cutting-edge approaches in blood cancer treatment.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.